HappeningToo topic
Golimumab reports
Browse community reports connected to Golimumab. These reports can show that other people are describing similar experiences, but they do not prove that Golimumab caused a symptom or reaction.
⚕️ Medicine safety note
Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.
22 problems
Abdominal Discomfort while using Golimumab
FDA FAERS contains adverse-event reports in which Golimumab and abdominal discomfort appear together. This does not establish that Golimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain Upper while using Golimumab
FDA FAERS contains adverse-event reports in which Golimumab and abdominal pain upper appear together. This does not establish that Golimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Alopecia while using Golimumab
FDA FAERS contains adverse-event reports in which Golimumab and alopecia appear together. This does not establish that Golimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Decreased Appetite while using Golimumab
FDA FAERS contains adverse-event reports in which Golimumab and decreased appetite appear together. This does not establish that Golimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Diarrhea while using Golimumab
FDA FAERS contains adverse-event reports in which Golimumab and diarrhea appear together. This does not establish that Golimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dizziness while using Golimumab
FDA FAERS contains adverse-event reports in which Golimumab and dizziness appear together. This does not establish that Golimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Fatigue while using Golimumab
FDA FAERS contains adverse-event reports in which Golimumab and fatigue appear together. This does not establish that Golimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Headache while using Golimumab
FDA FAERS contains adverse-event reports in which Golimumab and headache appear together. This does not establish that Golimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hives while using Golimumab
FDA FAERS contains adverse-event reports in which Golimumab and hives appear together. This does not establish that Golimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Insomnia while using Golimumab
FDA FAERS contains adverse-event reports in which Golimumab and insomnia appear together. This does not establish that Golimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Itching while using Golimumab
FDA FAERS contains adverse-event reports in which Golimumab and itching appear together. This does not establish that Golimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Malaise while using Golimumab
FDA FAERS contains adverse-event reports in which Golimumab and malaise appear together. This does not establish that Golimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Nausea while using Golimumab
FDA FAERS contains adverse-event reports in which Golimumab and nausea appear together. This does not establish that Golimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Night Sweats while using Golimumab
FDA FAERS contains adverse-event reports in which Golimumab and night sweats appear together. This does not establish that Golimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Pain while using Golimumab
FDA FAERS contains adverse-event reports in which Golimumab and pain appear together. This does not establish that Golimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash while using Golimumab
FDA FAERS contains adverse-event reports in which Golimumab and rash appear together. This does not establish that Golimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Shortness of breath while using Golimumab
FDA FAERS contains adverse-event reports in which Golimumab and shortness of breath appear together. This does not establish that Golimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Sleep Disorder while using Golimumab
FDA FAERS contains adverse-event reports in which Golimumab and sleep disorder appear together. This does not establish that Golimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Swelling while using Golimumab
FDA FAERS contains adverse-event reports in which Golimumab and swelling appear together. This does not establish that Golimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vomiting while using Golimumab
FDA FAERS contains adverse-event reports in which Golimumab and vomiting appear together. This does not establish that Golimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weakness while using Golimumab
FDA FAERS contains adverse-event reports in which Golimumab and weakness appear together. This does not establish that Golimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Increased while using Golimumab
FDA FAERS contains adverse-event reports in which Golimumab and weight increased appear together. This does not establish that Golimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →